Minister of State for Health Bharati Praveen Pawar told Rajya Sabha that all documents required for Emergency Use List (EUL) for COVID-19 vaccine Covaxin by Bharat Biotech have been submitted to WHO by July 9 and reviewed by the agency. The process has started. Tuesday.
Bharat Biotech has submitted all the documents required for the Emergency Use List (EUL) of its COVID-19 vaccine Covaxin to the World Health Organization (WHO) by July 9 and the review process by the agency has begun, said Minister of State for Health Bharati Praveen. Pawar informed the Rajya Sabha about this on Tuesday.
Asked whether it has come to the notice of the government that Covaxin used in India is not recognized by many countries, Pawar said the government is aware that currently Covaxin is on the WHO Emergency Use List (EUL). is not part.
Elaborating on the efforts made by the government to address the issue, Pawar said, “Bharat Biotech International Limited has submitted all the documents required for Emergency Use List (EUL) to WHO by 9 July 2021.” went.”
The review process has begun by WHO, which usually takes up to six weeks to decide on emergency use list (EUL) submissions, it said in a written reply.
(with PTI inputs)
Read also | Bharat Biotech’s Covaxin trial for children underway; Results expected by September: AIIMS chief
Read also | Decision on emergency use list for Covaxin likely in first week of August: WHO
.